Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kathryn Carlson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Anatomy
Physiology
Procedures
Phenomena
Disorders
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
64
Katzenellenbogen, John
17
Welch, Michael
14
Katzenellenbogen, Benita
6
Tamrazi, Anobel
6
VanBrocklin, Henry
5
Stossi, Fabio
5
Pomper, Martin
3
Sheng, Shubin
3
Sun, Jun
3
Meyers, Marvin
3
Compton, Dennis
3
Zhou, Hai-Bing
2
Gee, Arvin
2
Rapposelli, Simona
2
Gunther, Jillian Rebecca
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kathryn Carlson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Waibel Michael; Kieser Karen J; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3560-70.
-
2009: Waibel Michael; De Angelis Meri; Stossi Fabio; Kieser Karen J; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3412-24.
-
2009: LaFrate Andrew L; Carlson Kathryn E; Katzenellenbogen John A
Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.
Bioorganic & medicinal chemistry 2009;17(10):3528-35.
-
2009: Minutolo Filippo; Bertini Simone; Granchi Carlotta; Marchitiello Teresa; Prota Giovanni; Rapposelli Simona; Tuccinardi Tiziano; Martinelli Adriano; Gunther Jillian R; Carlson Kathryn E; Katzenellenbogen John A; Macchia Marco
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Journal of medicinal chemistry 2009;52(3):858-67.
-
2009: Zhou Hai-Bing; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity.
Bioorganic & medicinal chemistry letters 2009;19(1):108-10.
-
2008: LaFrate Andrew L; Gunther Jillian R; Carlson Kathryn E; Katzenellenbogen John A
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
Bioorganic & medicinal chemistry 2008;16(23):10075-84.
-
2008: Minutolo Filippo; Bellini Rosalba; Bertini Simone; Carboni Isabella; Lapucci Annalina; Pistolesi Letizia; Prota Giovanni; Rapposelli Simona; Solati Francesca; Tuccinardi Tiziano; Martinelli Adriano; Stossi Fabio; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A; Macchia Marco
Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
Journal of medicinal chemistry 2008;51(5):1344-51.
-
2007: Parent Ephraim E; Carlson Kathryn E; Katzenellenbogen John A
Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography.
The Journal of organic chemistry 2007;72(15):5546-54.
-
2007: Zhou Hai-Bing; Nettles Kendall W; Bruning John B; Kim Younchang; Joachimiak Andrzej; Sharma Sanjay; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Greene Geoffrey L; Katzenellenbogen John A
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands.
Chemistry & biology 2007;14(6):659-69.
-
2007: Zhou Hai-Bing; Sheng Shubin; Compton Dennis R; Kim Younchang; Joachimiak Andrzej; Sharma Sanjay; Carlson Kathryn E; Katzenellenbogen Benita S; Nettles Kendall W; Greene Geoffrey L; Katzenellenbogen John A
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
Journal of medicinal chemistry 2007;50(2):399-403.
-
2005: Tamrazi Anobel; Carlson Kathryn E; Rodriguez Alice L; Katzenellenbogen John A
Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Molecular endocrinology (Baltimore, Md.) 2005;19(6):1516-28.
-
2005: Kim Sung Hoon; Tamrazi Anobel; Carlson Kathryn E; Katzenellenbogen John A
A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality.
Molecular & cellular proteomics : MCP 2005;4(3):267-77.
-
2004: Compton Dennis R; Sheng Shubin; Carlson Kathryn E; Rebacz Natalie A; Lee In Young; Katzenellenbogen Benita S; Katzenellenbogen John A
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Journal of medicinal chemistry 2004;47(24):5872-93.
-
2004: Compton Dennis R; Carlson Kathryn E; Katzenellenbogen John A
Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core.
Bioorganic & medicinal chemistry letters 2004;14(22):5681-4.
-
2004: Kim Sung Hoon; Tamrazi Anobel; Carlson Kathryn E; Daniels Jonathan R; Lee In Young; Katzenellenbogen John A
Estrogen receptor microarrays: subtype-selective ligand binding.
Journal of the American Chemical Society 2004;126(15):4754-5.
-
2004: Hurth Kyle M; Nilges Mark J; Carlson Kathryn E; Tamrazi Anobel; Belford R Linn; Katzenellenbogen John A
Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
Biochemistry 2004;43(7):1891-907.
-
2003: Muthyala Rajeev S; Carlson Kathryn E; Katzenellenbogen John A
Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.
Bioorganic & medicinal chemistry letters 2003;13(24):4485-8.
-
2003: Tamrazi Anobel; Carlson Kathryn E; Katzenellenbogen John A
Molecular sensors of estrogen receptor conformations and dynamics.
Molecular endocrinology (Baltimore, Md.) 2003;17(12):2593-602.
-
2003: Muthyala Rajeev S; Sheng Shubin; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A
Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
Journal of medicinal chemistry 2003;46(9):1589-602.
-
2003: Ghosh Usha; Ganessunker Deshanie; Sattigeri Viswajanani J; Carlson Kathryn E; Mortensen Deborah J; Katzenellenbogen Benita S; Katzenellenbogen John A
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
Bioorganic & medicinal chemistry 2003;11(4):629-57.
-
2002: Tamrazi Anobel; Carlson Kathryn E; Daniels Jonathan R; Hurth Kyle M; Katzenellenbogen John A
Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.
Molecular endocrinology (Baltimore, Md.) 2002;16(12):2706-19.
-
2001: Meyers M J; Sun J; Carlson K E; Marriner G A; Katzenellenbogen B S; Katzenellenbogen J A
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
Journal of medicinal chemistry 2001;44(24):4230-51.
-
2001: Mortensen D S; Rodriguez A L; Carlson K E; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
Journal of medicinal chemistry 2001;44(23):3838-48.
-
1999: Gee A C; Carlson K E; Martini P G; Katzenellenbogen B S; Katzenellenbogen J A
Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Molecular endocrinology (Baltimore, Md.) 1999;13(11):1912-23.
-
1999: Meyers M J; Sun J; Carlson K E; Katzenellenbogen B S; Katzenellenbogen J A
Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Journal of medicinal chemistry 1999;42(13):2456-68.
-
1998: Meyers M J; Carlson K E; Katzenellenbogen J A
Facile synthesis of high affinity styrylpyridine systems as inherently fluorescent ligands for the estrogen receptor.
Bioorganic & medicinal chemistry letters 1998;8(24):3589-94.
-
1997: Carlson K E; Choi I; Gee A; Katzenellenbogen B S; Katzenellenbogen J A
Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Biochemistry 1997;36(48):14897-905.
-
1995: Seielstad D A; Carlson K E; Kushner P J; Greene G L; Katzenellenbogen J A
Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis.
Biochemistry 1995;34(39):12605-15.
-
1995: Seielstad D A; Carlson K E; Katzenellenbogen J A; Kushner P J; Greene G L
Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli.
Molecular endocrinology (Baltimore, Md.) 1995;9(6):647-58.
-
1995: Miksicek R J; Carlson K E; Hwang K J; Katzenellenbogen J A
Studies using fluorescent tetrahydrochrysene estrogens for in situ visualization of the estrogen receptor in living cells.
Molecular endocrinology (Baltimore, Md.) 1995;9(5):592-604.
-
1995: Kym P R; Carlson K E; Katzenellenbogen J A
Evaluation of a highly efficient aryl azide photoaffinity labeling reagent for the progesterone receptor.
Bioconjugate chemistry 1995;6(1):115-22.
-
1994: Bergmann K E; Wooge C H; Carlson K E; Katzenellenbogen B S; Katzenellenbogen J A
Bivalent ligands as probes of estrogen receptor action.
The Journal of steroid biochemistry and molecular biology 1994;49(2-3):139-52.
-
1994: O'Neil J P; Carlson K E; Anderson C J; Welch M J; Katzenellenbogen J A
Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
Bioconjugate chemistry 1994;5(3):182-93.
-
1994: Bergmann K E; Carlson K E; Katzenellenbogen J A
Hexestrol diazirine photoaffinity labeling reagent for the estrogen receptor.
Bioconjugate chemistry 1994;5(2):141-50.
-
1994: Bergmann K E; Landvatter S W; Rocque P G; Carlson K E; Welch M J; Katzenellenbogen J A
Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents.
Nuclear medicine and biology 1994;21(1):25-39.
-
1993: Anstead G M; Carlson K E; Kym P R; Hwang K J; Katzenellenbogen J A
The effect of acceptor group variation on the solvatochromism of donor-acceptor fluorophores.
Photochemistry and photobiology 1993;58(6):785-94.
-
1993: VanBrocklin H F; Carlson K E; Katzenellenbogen J A; Welch M J
16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
Journal of medicinal chemistry 1993;36(11):1619-29.
-
1993: Kochanny M J; VanBrocklin H F; Kym P R; Carlson K E; O'Neil J P; Bonasera T A; Welch M J; Katzenellenbogen J A
Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.
Journal of medicinal chemistry 1993;36(9):1120-7.
-
1993: Kym P R; Carlson K E; Katzenellenbogen J A
Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation.
Journal of medicinal chemistry 1993;36(9):1111-9.
-
1993: VanBrocklin H F; Rocque P A; Lee H V; Carlson K E; Katzenellenbogen J A; Welch M J
16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.
Life sciences 1993;53(10):811-9.
-
1992: Hwang K J; Carlson K E; Anstead G M; Katzenellenbogen J A
Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor.
Biochemistry 1992;31(46):11536-45.
-
1992: DiZio J P; Carlson K E; Bannochie C J; Welch M J; Von Angerer E; Katzenellenbogen J A
Estrogen platinum-diamine complexes: preparation of a non-steroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo.
The Journal of steroid biochemistry and molecular biology 1992;42(3-4):363-73.
-
1992: Liu A; Carlson K E; Katzenellenbogen J A
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
Journal of medicinal chemistry 1992;35(11):2113-29.
-
1992: Pomper M G; Kochanny M J; Thieme A M; Carlson K E; VanBrocklin H F; Mathias C J; Welch M J; Katzenellenbogen J A
Fluorine-substituted corticosteroids: synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(4):461-80.
-
1992: Pinney K G; Carlson K E; Katzenellenbogen J A
Nonsteroidal estrogens bearing acyl azide functions: potential electrophilic and photoaffinity labeling agents for the estrogen receptor.
Steroids 1992;57(5):222-32.
-
1992: VanBrocklin H F; Pomper M G; Carlson K E; Welch M J; Katzenellenbogen J A
Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(3):363-74.
-
1992: DiZio J P; Anderson C J; Davison A; Ehrhardt G J; Carlson K E; Welch M J; Katzenellenbogen J A
Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(4):558-69.
-
1991: Pinney K G; Carlson K E; Katzenellenbogen B S; Katzenellenbogen J A
Efficient and selective photoaffinity labeling of the estrogen receptor using two nonsteroidal ligands that embody aryl azide or tetrafluoroaryl azide photoreactive functions.
Biochemistry 1991;30(9):2421-31.
-
1990: Pomper M G; VanBrocklin H; Thieme A M; Thomas R D; Kiesewetter D O; Carlson K E; Mathias C J; Welch M J; Katzenellenbogen J A
11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
Journal of medicinal chemistry 1990;33(12):3143-55.
-
1990: Carlson K E; Katzenellenbogen J A
A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat.
Journal of steroid biochemistry 1990;36(6):549-61.
-
1990: Pinney K G; Carlson K E; Katzenellenbogen J A
[3H]DU41165: a high affinity ligand and novel photoaffinity labeling reagent for the progesterone receptor.
Journal of steroid biochemistry 1990;35(2):179-89.
-
1990: Pomper M G; Pinney K G; Carlson K E; van Brocklin H; Mathias C J; Welch M J; Katzenellenbogen J A
Target tissue uptake selectivity of three fluorine-substituted progestins: potential imaging agents for receptor-positive breast tumors.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(3):309-19.
-
1989: Carlson K E; Coppey M; Magdelenat H; Katzenellenbogen J A
Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations.
Journal of steroid biochemistry 1989;32(3):345-55.
-
1988: Bindal R D; Carlson K E; Katzenellenbogen B S; Katzenellenbogen J A
Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red.
Journal of steroid biochemistry 1988;31(3):287-93.
-
1988: Welch M J; Katzenellenbogen J A; Mathias C J; Brodack J W; Carlson K E; Chi D Y; Dence C S; Kilbourn M R; Perlmutter J S; Raichle M E
N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(1):83-97.
-
1988: Carlson K E; Brandes S J; Pomper M G; Katzenellenbogen J A
Uptake of three [3H]progestins by target tissues in vivo: implications for the design of diagnostic imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(4):403-8.
-
1987: Bindal R D; Carlson K E; Reiner G C; Katzenellenbogen J A
11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor.
Journal of steroid biochemistry 1987;28(4):361-70.
-
1987: Mathias C J; Welch M J; Katzenellenbogen J A; Brodack J W; Kilbourn M R; Carlson K E; Kiesewetter D O
Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(1):15-25.
-
1986: Salituro F G; Carlson K E; Elliston J F; Katzenellenbogen B S; Katzenellenbogen J A
[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
Steroids 1986;48(5-6):287-313.
-
1983: McElvany K D; Carlson K E; Katzenellenbogen J A; Welch M J
Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens.
Journal of steroid biochemistry 1983;18(6):635-41.
-
1982: Senderoff S G; McElvany K D; Carlson K E; Heiman D F; Katzenellenbogen J A; Welch M J
Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals.
The International journal of applied radiation and isotopes 1982;33(7):545-51.
-
1982: McElvany K D; Carlson K E; Welch M J; Senderoff S G; Katzenellenbogen J A
In vivo comparison of 16 alpha[77Br]bromoestradiol-17 beta and 16 alpha-[125I]iodoestradiol-17 beta.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(5):420-4.
-
1982: Katzenellenbogen J A; McElvany K D; Senderoff S G; Carlson K E; Landvatter S W; Welch M J
16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(5):411-9.
-
1980: Katzenellenbogen J A; Carlson K E; Heiman D F; Goswami R
Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(6):550-8.
Sign-in to see more